Becton, Dickinson & Co. (BDX)
184.29
-1.10
(-0.59%)
USD |
NYSE |
Feb 23, 16:00
184.29
0.00 (0.00%)
After-Hours: 19:59
Becton, Dickinson Research and Development Expense (Quarterly) : 306.00M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Baxter International, Inc. | 116.00M |
| Abbott Laboratories | 721.00M |
| Boston Scientific Corp. | 569.00M |
| West Pharmaceutical Services, Inc. | 21.80M |
| Integra LifeSciences Holdings Corp. | 20.42M |